2-tert-butyl-5-(3-methylimidazol-4-yl)pyridine;7-(6-tert-butylpyridazin-3-yl)-6,8-dihydro-5H-imidazo[1,5-a]pyrazine;1-[4-(6-tert-butylpyridazin-3-yl)piperazin-1-yl]butan-2-one;1-[4-(6-tert-butylpyridazin-3-yl)piperazin-1-yl]-4-methylpentan-2-one;2-[4-(6-tert-butylpyridazin-3-yl)piperazin-1-yl]-1-morpholin-4-ylethanone;2-[4-(6-tert-butylpyridazin-3-yl)piperazin-1-yl]-1-pyrrolidin-1-ylethanone;3-[(6-tert-butyl-3-pyridinyl)methyl]-5-methylimidazole-4-carboxylic acid;2-[4-[(6-tert-butyl-3-pyridinyl)methyl]piperazin-1-yl]acetonitrile;1-(6-tert-butyl-3-pyridinyl)-4-(2-oxobutyl)piperazin-2-one;2-[4-(6-tert-butyl-3-pyridinyl)-3-oxopiperazin-1-yl]-N,N-dimethylacetamide;3-tert-butyl-6-[4-(2,2,2-trifluoroethyl)piperazin-1-yl]pyridazine

C176H265F3N44O11 — CID 160851621

About 2-tert-butyl-5-(3-methylimidazol-4-yl)pyridine;7-(6-tert-butylpyridazin-3-yl)-6,8-dihydro-5H-imidazo[1,5-a]pyrazine;1-[4-(6-tert-butylpyridazin-3-yl)piperazin-1-yl]butan-2-one;1-[4-(6-tert-butylpyridazin-3-yl)piperazin-1-yl]-4-methylpentan-2-one;2-[4-(6-tert-butylpyridazin-3-yl)piperazin-1-yl]-1-morpholin-4-ylethanone;2-[4-(6-tert-butylpyridazin-3-yl)piperazin-1-yl]-1-pyrrolidin-1-ylethanone;3-[(6-tert-butyl-3-pyridinyl)methyl]-5-methylimidazole-4-carboxylic acid;2-[4-[(6-tert-butyl-3-pyridinyl)methyl]piperazin-1-yl]acetonitrile;1-(6-tert-butyl-3-pyridinyl)-4-(2-oxobutyl)piperazin-2-one;2-[4-(6-tert-butyl-3-pyridinyl)-3-oxopiperazin-1-yl]-N,N-dimethylacetamide;3-tert-butyl-6-[4-(2,2,2-trifluoroethyl)piperazin-1-yl]pyridazine

2-tert-butyl-5-(3-methylimidazol-4-yl)pyridine;7-(6-tert-butylpyridazin-3-yl)-6,8-dihydro-5H-imidazo[1,5-a]pyrazine;1-[4-(6-tert-butylpyridazin-3-yl)piperazin-1-yl]butan-2-one;1-[4-(6-tert-butylpyridazin-3-yl)piperazin-1-yl]-4-methylpentan-2-one;2-[4-(6-tert-butylpyridazin-3-yl)piperazin-1-yl]-1-morpholin-4-ylethanone;2-[4-(6-tert-butylpyridazin-3-yl)piperazin-1-yl]-1-pyrrolidin-1-ylethanone;3-[(6-tert-butyl-3-pyridinyl)methyl]-5-methylimidazole-4-carboxylic acid;2-[4-[(6-tert-butyl-3-pyridinyl)methyl]piperazin-1-yl]acetonitrile;1-(6-tert-butyl-3-pyridinyl)-4-(2-oxobutyl)piperazin-2-one;2-[4-(6-tert-butyl-3-pyridinyl)-3-oxopiperazin-1-yl]-N,N-dimethylacetamide;3-tert-butyl-6-[4-(2,2,2-trifluoroethyl)piperazin-1-yl]pyridazine (PubChem CID 160851621) has the molecular formula C176H265F3N44O11 and a molecular weight of 3230.35 g/mol. Its IUPAC name is 2-tert-butyl-5-(3-methylimidazol-4-yl)pyridine;7-(6-tert-butylpyridazin-3-yl)-6,8-dihydro-5H-imidazo[1,5-a]pyrazine;1-[4-(6-tert-butylpyridazin-3-yl)piperazin-1-yl]butan-2-one;1-[4-(6-tert-butylpyridazin-3-yl)piperazin-1-yl]-4-methylpentan-2-one;2-[4-(6-tert-butylpyridazin-3-yl)piperazin-1-yl]-1-morpholin-4-ylethanone;2-[4-(6-tert-butylpyridazin-3-yl)piperazin-1-yl]-1-pyrrolidin-1-ylethanone;3-[(6-tert-butyl-3-pyridinyl)methyl]-5-methylimidazole-4-carboxylic acid;2-[4-[(6-tert-butyl-3-pyridinyl)methyl]piperazin-1-yl]acetonitrile;1-(6-tert-butyl-3-pyridinyl)-4-(2-oxobutyl)piperazin-2-one;2-[4-(6-tert-butyl-3-pyridinyl)-3-oxopiperazin-1-yl]-N,N-dimethylacetamide;3-tert-butyl-6-[4-(2,2,2-trifluoroethyl)piperazin-1-yl]pyridazine.

Molecular Properties

• Compound Name: 2-tert-butyl-5-(3-methylimidazol-4-yl)pyridine;7-(6-tert-butylpyridazin-3-yl)-6,8-dihydro-5H-imidazo[1,5-a]pyrazine;1-[4-(6-tert-butylpyridazin-3-yl)piperazin-1-yl]butan-2-one;1-[4-(6-tert-butylpyridazin-3-yl)piperazin-1-yl]-4-methylpentan-2-one;2-[4-(6-tert-butylpyridazin-3-yl)piperazin-1-yl]-1-morpholin-4-ylethanone;2-[4-(6-tert-butylpyridazin-3-yl)piperazin-1-yl]-1-pyrrolidin-1-ylethanone;3-[(6-tert-butyl-3-pyridinyl)methyl]-5-methylimidazole-4-carboxylic acid;2-[4-[(6-tert-butyl-3-pyridinyl)methyl]piperazin-1-yl]acetonitrile;1-(6-tert-butyl-3-pyridinyl)-4-(2-oxobutyl)piperazin-2-one;2-[4-(6-tert-butyl-3-pyridinyl)-3-oxopiperazin-1-yl]-N,N-dimethylacetamide;3-tert-butyl-6-[4-(2,2,2-trifluoroethyl)piperazin-1-yl]pyridazine
• PubChem CID: 160851621
• Molecular Formula: C176H265F3N44O11
• Molecular Weight: 3230.35 g/mol
• Exact Mass: 3228.15
• IUPAC Name: 2-tert-butyl-5-(3-methylimidazol-4-yl)pyridine;7-(6-tert-butylpyridazin-3-yl)-6,8-dihydro-5H-imidazo[1,5-a]pyrazine;1-[4-(6-tert-butylpyridazin-3-yl)piperazin-1-yl]butan-2-one;1-[4-(6-tert-butylpyridazin-3-yl)piperazin-1-yl]-4-methylpentan-2-one;2-[4-(6-tert-butylpyridazin-3-yl)piperazin-1-yl]-1-morpholin-4-ylethanone;2-[4-(6-tert-butylpyridazin-3-yl)piperazin-1-yl]-1-pyrrolidin-1-ylethanone;3-[(6-tert-butyl-3-pyridinyl)methyl]-5-methylimidazole-4-carboxylic acid;2-[4-[(6-tert-butyl-3-pyridinyl)methyl]piperazin-1-yl]acetonitrile;1-(6-tert-butyl-3-pyridinyl)-4-(2-oxobutyl)piperazin-2-one;2-[4-(6-tert-butyl-3-pyridinyl)-3-oxopiperazin-1-yl]-N,N-dimethylacetamide;3-tert-butyl-6-[4-(2,2,2-trifluoroethyl)piperazin-1-yl]pyridazine
• SMILES: CC(C)(C)c1ccc(CN2CCN(CC#N)CC2)cn1.CC(C)(C)c1ccc(N2CCN(CC(=O)N3CCCC3)CC2)nn1.CC(C)(C)c1ccc(N2CCN(CC(=O)N3CCOCC3)CC2)nn1.CC(C)(C)c1ccc(N2CCN(CC(F)(F)F)CC2)nn1.CC(C)(C)c1ccc(N2CCn3cncc3C2)nn1.CC(C)CC(=O)CN1CCN(c2ccc(C(C)(C)C)nn2)CC1.CCC(=O)CN1CCN(c2ccc(C(C)(C)C)nc2)C(=O)C1.CCC(=O)CN1CCN(c2ccc(C(C)(C)C)nn2)CC1.CN(C)C(=O)CN1CCN(c2ccc(C(C)(C)C)nc2)C(=O)C1.Cc1ncn(Cc2ccc(C(C)(C)C)nc2)c1C(=O)O.Cn1cncc1-c1ccc(C(C)(C)C)nc1
• InChI: InChI=1S/C18H29N5O2.C18H29N5O.C18H30N4O.C17H26N4O2.C17H25N3O2.C16H26N4O.C16H24N4.C15H19N3O2.C14H21F3N4.C14H19N5.C13H17N3/c1-18(2,3)15-4-5-16(20-19-15)22-8-6-21(7-9-22)14-17(24)23-10-12-25-13-11-23;1-18(2,3)15-6-7-16(20-19-15)22-12-10-21(11-13-22)14-17(24)23-8-4-5-9-23;1-14(2)12-15(23)13-21-8-10-22(11-9-21)17-7-6-16(19-20-17)18(3,4)5;1-17(2,3)14-7-6-13(10-18-14)21-9-8-20(12-16(21)23)11-15(22)19(4)5;1-5-14(21)11-19-8-9-20(16(22)12-19)13-6-7-15(18-10-13)17(2,3)4;1-5-13(21)12-19-8-10-20(11-9-19)15-7-6-14(17-18-15)16(2,3)4;1-16(2,3)15-5-4-14(12-18-15)13-20-10-8-19(7-6-17)9-11-20;1-10-13(14(19)20)18(9-17-10)8-11-5-6-12(16-7-11)15(2,3)4;1-13(2,3)11-4-5-12(19-18-11)21-8-6-20(7-9-21)10-14(15,16)17;1-14(2,3)12-4-5-13(17-16-12)18-6-7-19-10-15-8-11(19)9-18;1-13(2,3)12-6-5-10(7-15-12)11-8-14-9-16(11)4/h4-5H,6-14H2,1-3H3;6-7H,4-5,8-14H2,1-3H3;6-7,14H,8-13H2,1-5H3;6-7,10H,8-9,11-12H2,1-5H3;6-7,10H,5,8-9,11-12H2,1-4H3;6-7H,5,8-12H2,1-4H3;4-5,12H,7-11,13H2,1-3H3;5-7,9H,8H2,1-4H3,(H,19,20);4-5H,6-10H2,1-3H3;4-5,8,10H,6-7,9H2,1-3H3;5-9H,1-4H3
• InChIKey: SJIHOMDGSPDMEG-UHFFFAOYSA-N
• XLogP: 21.66
• TPSA: 544.27 Ų
• H-Bond Donors: 1
• H-Bond Acceptors: 49
• Rotatable Bonds: 32
• Heavy Atoms: 234
• Complexity: —

Lipinski Rule of Five

3 violations

Rule	Value
MW ≤ 500	3230.35
LogP ≤ 5	21.66
H-Bond Donors ≤ 5	1
H-Bond Acceptors ≤ 10	49

Computed Properties (RDKit)

• Structural Alerts: {'alert_name': 'cyanamide', 'substructure': 'N/A'}

Frequently Asked Questions

What is the IUPAC name of 2-tert-butyl-5-(3-methylimidazol-4-yl)pyridine;7-(6-tert-butylpyridazin-3-yl)-6,8-dihydro-5H-imidazo[1,5-a]pyrazine;1-[4-(6-tert-butylpyridazin-3-yl)piperazin-1-yl]butan-2-one;1-[4-(6-tert-butylpyridazin-3-yl)piperazin-1-yl]-4-methylpentan-2-one;2-[4-(6-tert-butylpyridazin-3-yl)piperazin-1-yl]-1-morpholin-4-ylethanone;2-[4-(6-tert-butylpyridazin-3-yl)piperazin-1-yl]-1-pyrrolidin-1-ylethanone;3-[(6-tert-butyl-3-pyridinyl)methyl]-5-methylimidazole-4-carboxylic acid;2-[4-[(6-tert-butyl-3-pyridinyl)methyl]piperazin-1-yl]acetonitrile;1-(6-tert-butyl-3-pyridinyl)-4-(2-oxobutyl)piperazin-2-one;2-[4-(6-tert-butyl-3-pyridinyl)-3-oxopiperazin-1-yl]-N,N-dimethylacetamide;3-tert-butyl-6-[4-(2,2,2-trifluoroethyl)piperazin-1-yl]pyridazine?

The IUPAC name of 2-tert-butyl-5-(3-methylimidazol-4-yl)pyridine;7-(6-tert-butylpyridazin-3-yl)-6,8-dihydro-5H-imidazo[1,5-a]pyrazine;1-[4-(6-tert-butylpyridazin-3-yl)piperazin-1-yl]butan-2-one;1-[4-(6-tert-butylpyridazin-3-yl)piperazin-1-yl]-4-methylpentan-2-one;2-[4-(6-tert-butylpyridazin-3-yl)piperazin-1-yl]-1-morpholin-4-ylethanone;2-[4-(6-tert-butylpyridazin-3-yl)piperazin-1-yl]-1-pyrrolidin-1-ylethanone;3-[(6-tert-butyl-3-pyridinyl)methyl]-5-methylimidazole-4-carboxylic acid;2-[4-[(6-tert-butyl-3-pyridinyl)methyl]piperazin-1-yl]acetonitrile;1-(6-tert-butyl-3-pyridinyl)-4-(2-oxobutyl)piperazin-2-one;2-[4-(6-tert-butyl-3-pyridinyl)-3-oxopiperazin-1-yl]-N,N-dimethylacetamide;3-tert-butyl-6-[4-(2,2,2-trifluoroethyl)piperazin-1-yl]pyridazine (CID 160851621) is 2-tert-butyl-5-(3-methylimidazol-4-yl)pyridine;7-(6-tert-butylpyridazin-3-yl)-6,8-dihydro-5H-imidazo[1,5-a]pyrazine;1-[4-(6-tert-butylpyridazin-3-yl)piperazin-1-yl]butan-2-one;1-[4-(6-tert-butylpyridazin-3-yl)piperazin-1-yl]-4-methylpentan-2-one;2-[4-(6-tert-butylpyridazin-3-yl)piperazin-1-yl]-1-morpholin-4-ylethanone;2-[4-(6-tert-butylpyridazin-3-yl)piperazin-1-yl]-1-pyrrolidin-1-ylethanone;3-[(6-tert-butyl-3-pyridinyl)methyl]-5-methylimidazole-4-carboxylic acid;2-[4-[(6-tert-butyl-3-pyridinyl)methyl]piperazin-1-yl]acetonitrile;1-(6-tert-butyl-3-pyridinyl)-4-(2-oxobutyl)piperazin-2-one;2-[4-(6-tert-butyl-3-pyridinyl)-3-oxopiperazin-1-yl]-N,N-dimethylacetamide;3-tert-butyl-6-[4-(2,2,2-trifluoroethyl)piperazin-1-yl]pyridazine.

What is the SMILES notation for 2-tert-butyl-5-(3-methylimidazol-4-yl)pyridine;7-(6-tert-butylpyridazin-3-yl)-6,8-dihydro-5H-imidazo[1,5-a]pyrazine;1-[4-(6-tert-butylpyridazin-3-yl)piperazin-1-yl]butan-2-one;1-[4-(6-tert-butylpyridazin-3-yl)piperazin-1-yl]-4-methylpentan-2-one;2-[4-(6-tert-butylpyridazin-3-yl)piperazin-1-yl]-1-morpholin-4-ylethanone;2-[4-(6-tert-butylpyridazin-3-yl)piperazin-1-yl]-1-pyrrolidin-1-ylethanone;3-[(6-tert-butyl-3-pyridinyl)methyl]-5-methylimidazole-4-carboxylic acid;2-[4-[(6-tert-butyl-3-pyridinyl)methyl]piperazin-1-yl]acetonitrile;1-(6-tert-butyl-3-pyridinyl)-4-(2-oxobutyl)piperazin-2-one;2-[4-(6-tert-butyl-3-pyridinyl)-3-oxopiperazin-1-yl]-N,N-dimethylacetamide;3-tert-butyl-6-[4-(2,2,2-trifluoroethyl)piperazin-1-yl]pyridazine?

The canonical SMILES for 2-tert-butyl-5-(3-methylimidazol-4-yl)pyridine;7-(6-tert-butylpyridazin-3-yl)-6,8-dihydro-5H-imidazo[1,5-a]pyrazine;1-[4-(6-tert-butylpyridazin-3-yl)piperazin-1-yl]butan-2-one;1-[4-(6-tert-butylpyridazin-3-yl)piperazin-1-yl]-4-methylpentan-2-one;2-[4-(6-tert-butylpyridazin-3-yl)piperazin-1-yl]-1-morpholin-4-ylethanone;2-[4-(6-tert-butylpyridazin-3-yl)piperazin-1-yl]-1-pyrrolidin-1-ylethanone;3-[(6-tert-butyl-3-pyridinyl)methyl]-5-methylimidazole-4-carboxylic acid;2-[4-[(6-tert-butyl-3-pyridinyl)methyl]piperazin-1-yl]acetonitrile;1-(6-tert-butyl-3-pyridinyl)-4-(2-oxobutyl)piperazin-2-one;2-[4-(6-tert-butyl-3-pyridinyl)-3-oxopiperazin-1-yl]-N,N-dimethylacetamide;3-tert-butyl-6-[4-(2,2,2-trifluoroethyl)piperazin-1-yl]pyridazine is CC(C)(C)c1ccc(CN2CCN(CC#N)CC2)cn1.CC(C)(C)c1ccc(N2CCN(CC(=O)N3CCCC3)CC2)nn1.CC(C)(C)c1ccc(N2CCN(CC(=O)N3CCOCC3)CC2)nn1.CC(C)(C)c1ccc(N2CCN(CC(F)(F)F)CC2)nn1.CC(C)(C)c1ccc(N2CCn3cncc3C2)nn1.CC(C)CC(=O)CN1CCN(c2ccc(C(C)(C)C)nn2)CC1.CCC(=O)CN1CCN(c2ccc(C(C)(C)C)nc2)C(=O)C1.CCC(=O)CN1CCN(c2ccc(C(C)(C)C)nn2)CC1.CN(C)C(=O)CN1CCN(c2ccc(C(C)(C)C)nc2)C(=O)C1.Cc1ncn(Cc2ccc(C(C)(C)C)nc2)c1C(=O)O.Cn1cncc1-c1ccc(C(C)(C)C)nc1.

What is the InChIKey of 2-tert-butyl-5-(3-methylimidazol-4-yl)pyridine;7-(6-tert-butylpyridazin-3-yl)-6,8-dihydro-5H-imidazo[1,5-a]pyrazine;1-[4-(6-tert-butylpyridazin-3-yl)piperazin-1-yl]butan-2-one;1-[4-(6-tert-butylpyridazin-3-yl)piperazin-1-yl]-4-methylpentan-2-one;2-[4-(6-tert-butylpyridazin-3-yl)piperazin-1-yl]-1-morpholin-4-ylethanone;2-[4-(6-tert-butylpyridazin-3-yl)piperazin-1-yl]-1-pyrrolidin-1-ylethanone;3-[(6-tert-butyl-3-pyridinyl)methyl]-5-methylimidazole-4-carboxylic acid;2-[4-[(6-tert-butyl-3-pyridinyl)methyl]piperazin-1-yl]acetonitrile;1-(6-tert-butyl-3-pyridinyl)-4-(2-oxobutyl)piperazin-2-one;2-[4-(6-tert-butyl-3-pyridinyl)-3-oxopiperazin-1-yl]-N,N-dimethylacetamide;3-tert-butyl-6-[4-(2,2,2-trifluoroethyl)piperazin-1-yl]pyridazine?

The InChIKey is SJIHOMDGSPDMEG-UHFFFAOYSA-N. The full InChI is InChI=1S/C18H29N5O2.C18H29N5O.C18H30N4O.C17H26N4O2.C17H25N3O2.C16H26N4O.C16H24N4.C15H19N3O2.C14H21F3N4.C14H19N5.C13H17N3/c1-18(2,3)15-4-5-16(20-19-15)22-8-6-21(7-9-22)14-17(24)23-10-12-25-13-11-23;1-18(2,3)15-6-7-16(20-19-15)22-12-10-21(11-13-22)14-17(24)23-8-4-5-9-23;1-14(2)12-15(23)13-21-8-10-22(11-9-21)17-7-6-16(19-20-17)18(3,4)5;1-17(2,3)14-7-6-13(10-18-14)21-9-8-20(12-16(21)23)11-15(22)19(4)5;1-5-14(21)11-19-8-9-20(16(22)12-19)13-6-7-15(18-10-13)17(2,3)4;1-5-13(21)12-19-8-10-20(11-9-19)15-7-6-14(17-18-15)16(2,3)4;1-16(2,3)15-5-4-14(12-18-15)13-20-10-8-19(7-6-17)9-11-20;1-10-13(14(19)20)18(9-17-10)8-11-5-6-12(16-7-11)15(2,3)4;1-13(2,3)11-4-5-12(19-18-11)21-8-6-20(7-9-21)10-14(15,16)17;1-14(2,3)12-4-5-13(17-16-12)18-6-7-19-10-15-8-11(19)9-18;1-13(2,3)12-6-5-10(7-15-12)11-8-14-9-16(11)4/h4-5H,6-14H2,1-3H3;6-7H,4-5,8-14H2,1-3H3;6-7,14H,8-13H2,1-5H3;6-7,10H,8-9,11-12H2,1-5H3;6-7,10H,5,8-9,11-12H2,1-4H3;6-7H,5,8-12H2,1-4H3;4-5,12H,7-11,13H2,1-3H3;5-7,9H,8H2,1-4H3,(H,19,20);4-5H,6-10H2,1-3H3;4-5,8,10H,6-7,9H2,1-3H3;5-9H,1-4H3.

What are the key properties of 2-tert-butyl-5-(3-methylimidazol-4-yl)pyridine;7-(6-tert-butylpyridazin-3-yl)-6,8-dihydro-5H-imidazo[1,5-a]pyrazine;1-[4-(6-tert-butylpyridazin-3-yl)piperazin-1-yl]butan-2-one;1-[4-(6-tert-butylpyridazin-3-yl)piperazin-1-yl]-4-methylpentan-2-one;2-[4-(6-tert-butylpyridazin-3-yl)piperazin-1-yl]-1-morpholin-4-ylethanone;2-[4-(6-tert-butylpyridazin-3-yl)piperazin-1-yl]-1-pyrrolidin-1-ylethanone;3-[(6-tert-butyl-3-pyridinyl)methyl]-5-methylimidazole-4-carboxylic acid;2-[4-[(6-tert-butyl-3-pyridinyl)methyl]piperazin-1-yl]acetonitrile;1-(6-tert-butyl-3-pyridinyl)-4-(2-oxobutyl)piperazin-2-one;2-[4-(6-tert-butyl-3-pyridinyl)-3-oxopiperazin-1-yl]-N,N-dimethylacetamide;3-tert-butyl-6-[4-(2,2,2-trifluoroethyl)piperazin-1-yl]pyridazine?

2-tert-butyl-5-(3-methylimidazol-4-yl)pyridine;7-(6-tert-butylpyridazin-3-yl)-6,8-dihydro-5H-imidazo[1,5-a]pyrazine;1-[4-(6-tert-butylpyridazin-3-yl)piperazin-1-yl]butan-2-one;1-[4-(6-tert-butylpyridazin-3-yl)piperazin-1-yl]-4-methylpentan-2-one;2-[4-(6-tert-butylpyridazin-3-yl)piperazin-1-yl]-1-morpholin-4-ylethanone;2-[4-(6-tert-butylpyridazin-3-yl)piperazin-1-yl]-1-pyrrolidin-1-ylethanone;3-[(6-tert-butyl-3-pyridinyl)methyl]-5-methylimidazole-4-carboxylic acid;2-[4-[(6-tert-butyl-3-pyridinyl)methyl]piperazin-1-yl]acetonitrile;1-(6-tert-butyl-3-pyridinyl)-4-(2-oxobutyl)piperazin-2-one;2-[4-(6-tert-butyl-3-pyridinyl)-3-oxopiperazin-1-yl]-N,N-dimethylacetamide;3-tert-butyl-6-[4-(2,2,2-trifluoroethyl)piperazin-1-yl]pyridazine has a molecular weight of 3230.35 g/mol, XLogP of 21.66, 32 rotatable bonds, 1 hydrogen bond donors, and 49 hydrogen bond acceptors.

Where does this data come from?

All data for 2-tert-butyl-5-(3-methylimidazol-4-yl)pyridine;7-(6-tert-butylpyridazin-3-yl)-6,8-dihydro-5H-imidazo[1,5-a]pyrazine;1-[4-(6-tert-butylpyridazin-3-yl)piperazin-1-yl]butan-2-one;1-[4-(6-tert-butylpyridazin-3-yl)piperazin-1-yl]-4-methylpentan-2-one;2-[4-(6-tert-butylpyridazin-3-yl)piperazin-1-yl]-1-morpholin-4-ylethanone;2-[4-(6-tert-butylpyridazin-3-yl)piperazin-1-yl]-1-pyrrolidin-1-ylethanone;3-[(6-tert-butyl-3-pyridinyl)methyl]-5-methylimidazole-4-carboxylic acid;2-[4-[(6-tert-butyl-3-pyridinyl)methyl]piperazin-1-yl]acetonitrile;1-(6-tert-butyl-3-pyridinyl)-4-(2-oxobutyl)piperazin-2-one;2-[4-(6-tert-butyl-3-pyridinyl)-3-oxopiperazin-1-yl]-N,N-dimethylacetamide;3-tert-butyl-6-[4-(2,2,2-trifluoroethyl)piperazin-1-yl]pyridazine is sourced from PubChem (CID 160851621), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).